The journal Safety and Risk of Pharmacotherapy has been indexed in Scopus and, based on the evaluation results, assigned to the second quartile (Q2). This achievement reflects the years-long systematic work of the editorial board, the high level of expertise of its specialists, and the active commitment of the editorial team to raising the standards of scientific publishing.

″Attaining a Q2 ranking is not a chance success but the logical outcome of focused, deliberate efforts. Over the past several years, the journal team has consistently improved the quality of peer review, the methodological rigor of articles, and ethical standards. We have engaged leading experts and worked to establish the journal as a truly authoritative platform for sharing cutting-edge scientific knowledge″, stated Professor Renad N. Alyautdin, Editor-in-Chief of the journal.

The next stage involves updating the manuscript submission guidelines and adopting more stringent selection criteria (including requirements for the reproducibility of research results and the regulation of generative artificial intelligence technologies) to maintain the journal’s current standing and further enhance its quality. These measures will help strengthen the journal’s role as a sought-after and authoritative platform for scientific communication, including at the international level.

We express our gratitude to the scientific community, our reviewers, and our readers for their trust and support. Through our joint efforts, we continue to strive for new scientific heights.

Scopus: https://www.scopus.com/sourceid/21101363484